Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Mol Nutr Food Res. 2012 Jun 6;56(8):1333–1341. doi: 10.1002/mnfr.201100719

Table 3.

Demographic and baseline characteristics of the trial subjects.

Placebo (n=25) Chromium Picolinate (n=25) Chromium Dinicocysteinate (n=24)
Age (years) 48.64±1.99 51.12±2.03 48.79±1.82
Gender: male/female (%) 2/23 (8.70%) 7/18 (38.89%) 8/16 (50%)
Weight (kg) 100.47±5.52 103.94±6.39 104.31±6.93
BMI 38.00±1.71 35.44±2.06 36.85±2.20
Fasting Glucose (mg/dL) 142.4±12.32 128.88±8.78 131.95±9.61
HbA1C (%) 7.84±0.34 7.54±0.32 7.65±0.35

Where applicable, values are expressed as Mean ± SEM. No significant difference was observed among the groups.